Charles Bachtell

Trulieve Launches Rec Marijuana Sales In CT Trulieve Cannabis Corp.'s (CSE: TRUL) (OTCQX: TCNNF) new dispensary in Bristol, Connecticut, started selling adult-use cannabis products on Friday, Feb 17. Recently relocated to 820 Farmington Ave., the company's hybrid (medical and adult-use)...

Cresco Expands Retail Footprint In FL Cresco Labs (CSE: CL) (OTCQX: CRLBF) announced the opening of a new Sunnyside dispensary in Lutz, Florida. Sunnyside Lutz is the company's 22nd dispensary in the Sunshine State and 56th dispensary nationwide. “We are pleased to expand the reach of...

Cresco Labs Inc. (CSE:CL) (OTCQX: CRLBF) (FSE:6CQ) Q3 2022 revenue was $210 million, down 2% year-over-year. Q3 2022 Financial Highlights Gross profit of $99.1 million or 47% of revenue, compared to gross profit of $108.3 million or 50% of revenue in Q3 2021. Adjusted EBITDA of $41.7 million,...

Cresco Labs (OTCQX: CRLBF) (CSE:CL) has completed and closed on an agreement to sell its Brookville, PA property to Aventine Property Group for total additional non-dilutive funding of $45 million. The Brookville, PA property includes approximately 135,000 square feet of existing cultivation,...

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-over-year increase in revenue to $218 million. The transaction with Columbia Care Inc. (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) (FSE: 3LP) is proceeding...

Cresco Labs Inc. (CSE:CL) (OTCQX: CRLBF) (FSE:6CQ) released its financial results for the quarter ended June 30, 2022, revealing revenue of $218 million, up 4% year-over-year. Q2 2022 Financial Highlights Adjusted gross profit of $116 million, or 53% of revenue, an increase of 8% year-over-year,...

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) (FSE:6CQ) released its financial results for the three months ended March 31, 2022, revealing revenue of $214 million, up 20% year-over-year. Q1 2022 Financial Highlights Gross profit excluding fair value mark-up for acquired inventory of $113 million, or...

The 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with Cresco Labs' (CSE:CL) (OTCQX: CRLBF) proposed acquisition of Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX: CCHWF) has expired. “Completion of the HSR milestone is a major...

Cresco Labs (OTCQX: CRLBF) (CSE:CL) launched its premium craft brand FloraCal Farms, which features curated flower, live rosin vape and live rosin concentrate formats now available at all Illinois Sunnyside stores and other retailers ahead of the 420 cannabis holiday. “FloraCal Farms...

Vertically integrated cannabis company Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced its financial results Thursday for the third quarter ended September 30, 2021, reporting revenue of $215.5 million, up by 40.6% year-over-year. Q3 Financial Highlights Adjusted EBITDA of $56...

Vertically integrated cannabis company Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) reported a 9.9% quarter-over-quarter and 168.8% year-over-year revenue growth amounting to $178 million in the first quarter of 2021. The Chicago-based company achieved record wholesale and retail revenue...

Cannabis company Cresco Labs (CSE:CL) (OTCQX: CRLBF) is taking over Massachusetts-based Cultivate Licensing LLC and BL Real Estate LLC for a total of $158 million. The sum includes an upfront payment of $90 million, consisting of $15 million in cash and $75 million in Cresco’s...